therapeutics in English

noun

[,ther·a'peu·tics || ‚ðerəpjuːtɪks]

branch of medicine dealing with healing remedies

Use "therapeutics" in a sentence

Below are sample sentences containing the word "therapeutics" from the English Dictionary. We can refer to these sentence patterns for sentences in case of finding sample sentences with the word "therapeutics", or refer to the context using the word "therapeutics" in the English Dictionary.

1. About Akebia Therapeutics Akebia Therapeutics, Inc

2. Allopathy+homeopathic Therapeutics

3. 8 Allogene Therapeutics reviews

4. ©2021 Akebia Therapeutics, Inc

5. In Q4, Akebia Therapeutics brought

6. Ascidian THERAPEUTICS, INC (Delaware (US))

7. Acrs Complete Aclaris Therapeutics Inc

8. Cancer startup Allogene Therapeutics Inc

9. Atalanta Therapeutics General Information Description

10. Cedilla Therapeutics General Information Description

11. View the latest Allogene Therapeutics Inc

12. Cere Complete Cerevel Therapeutics Holdings Inc

13. Allogene Therapeutics 25,382 followers on LinkedIn

14. 22, 2021-- Arcturus Therapeutics Holdings Inc

15. About Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering …

16. 08, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc

17. Allogene Therapeutics is funded by 14 investors.

18. Bellerophon Therapeutics (BLPH) Reports Q3 Loss, Lags Revenue Estimates Bellerophon Therapeutics (BLPH) delivered earnings and revenue surprises of -2.44% and …

19. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases.

20. 23, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc

21. Crispr Therapeutics to Participate in Upcoming Investor Conferences

22. Biosimilar adjective Referring to a Biosimilar therapeutics agent

23. A high-level overview of Beam Therapeutics Inc

24. Allogene Therapeutics is now valued at $5 billion

25. Allogene Therapeutics is registered under the ticker NASDAQ:ALLO

26. AKBA Akebia Therapeutics — Stock Price and Discussion Stocktwits

27. A high-level overview of Aprea Therapeutics, Inc

28. Antisense oligonucleotide-based therapeutics involves downregulation of gene expression

29. View Aclaris Therapeutics, Inc. Acrs investment & stock information

30. Allogene Therapeutics is a clinical stage immuno-oncology company

31. Get the lAtest stock price for Antibe Therapeutics Inc

32. Akebia Therapeutics NASDAQ Updated Jun 25, 2021 11:50 PM

33. Biom Therapeutics Bio-pharmaceutical company developing therapeutics for rare neurological childhood diseases Learn More A B O U T U S Biom Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for brain disorders

34. Neuralstem (Cur) Stock Rises Today as Brainstorm Cell Therapeutics Soars

35. A high-level overview of Alterity Therapeutics Limited (Athe) stock

36. Beam Therapeutics has received 64.29% “underperform” votes from our community

37. Crisper Therapeutics shares decline on wider-than-expected loss Jul

38. Aprea Therapeutics PRIVATE Updated Mar 25, 2021 8:45 AM

39. Antisense & RNAi Therapeutics Market Regional And Country Analysis 5.1

40. Bellerophon Therapeutics NASDAQ Updated Mar 24, 2021 11:54 PM

41. You are leaving Akebia.com, a website of Akebia Therapeutics, Inc

42. Antisense & RNAi Therapeutics Market Regional And Country Analysis 5.1

43. Aileron Therapeutics NASDAQ Updated Mar 19, 2021 11:57 PM

44. Get the latest Aclaris Therapeutics, Inc. Acrs detailed stock quotes, …

45. Crispr Therapeutics has established a portfolio of therapeutic programs across a

46. During Q1, Akebia Therapeutics (NASDAQ:AKBA) brought in sales totaling $52.30 million

47. During Q1, Akebia Therapeutics (NASDAQ:AKBA) brought in sales totaling $52.30 million

48. The Biologic therapeutics market analysis includes the product segment and geographic landscape

49. What does Aceology mean? The science of remedies, or of therapeutics; iamatology

50. Aprea Therapeutics started at neutral with $23 stock price target at J.P